Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis
Sponsored by University of Michigan
About this study
This study is being done to better understand how the study team can treat pain for people with cirrhosis and depression. Enrolled participants on this feasibility study will be randomized to Transcutaneous Electrical Acustimulation (TEA) or sham TEA.
Where this study is enrolling (2)
- I'm interested
University of Michigan
Ann Arbor, Michigan
- I'm interested
University of Pennsylvania
Philadelphia, Pennsylvania
Who can participate
Inclusion criteria
- ✓Diagnosis of cirrhosis - must meet the criteria as outlined in the protocol
- ✓Chronic pain (Patient self-reports ≥ 4 on the 0-10 scale for \>50% of days within 3- months)
- ✓Willing to use a Transcutaneous Electrical Acustimulation (TEA) device
- ✓Has access to Wi-Fi or a data plan
- ✓Has access to a laptop, computer, tablet, or smartphone
Exclusion criteria
- ✕Dementia and/or severe cognitive impairment
- ✕Unable or unwilling to provide consent
- ✕Expected to undergo liver transplant in next 24 weeks
- ✕No email address
- ✕Deemed unsuitable by the study investigator
- ✕Model for End-Stage Liver Diseas (MELD) score \>25, or total bilirubin \>4.0 in a patient on hemodialysis
- ✕Recent hospitalization (\>24 hours) or episode of hepatic encephalopathy within the preceding 30 days
- ✕Implanted pacemaker/defibrillator, spinal implant, or cochlear implant
- ✕Known allergy to adhesive tape/electrode materials
- ✕Current active suicidal ideation, endorsed at screening (see Section 8.6)
- ✕Currently pregnant (self-reported)
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.